Mackenzie Financial’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,422
Closed -$277K 1703
2024
Q4
$277K Buy
5,422
+440
+9% +$22.5K ﹤0.01% 1418
2024
Q3
$255K Buy
+4,982
New +$255K ﹤0.01% 1263
2023
Q3
Sell
-14,909
Closed -$269K 1494
2023
Q2
$269K Buy
+14,909
New +$269K ﹤0.01% 1206